Nigel Silman is the Strategic R&D Lead at Public Health England’s Porton Down Centre in the UK and has over 30 years’ experience working in with a range of viral and bacterial pathogens in high-containment laboratories. He was educated at the Universities of Plymouth and Leicester and has a background in microbial physiology & biochemistry, particularly in relation to control of biochemical and biosynthetic pathways. His research interests include process development of industrial enzymes, pharmaceutical proteins and detection & diagnosis of infectious diseases and he currently has active projects on Anthrax, Salmonella typhi and influenza. He has worked in both academic and industrial settings and has been at Porton Down for the last 18 years. He is the PHE research lead for Diagnostics and Detection and also responsible for the scientific overview of specialist reference and contract microbiology services for a range of exotic & emerging infectious diseases as well as developing and leading the strategic R&D direction for the Centre. He holds a visiting Chair in Infectious Disease at the University of the West of England, Bristol and he is also the CEO and Managing Director of WiltonBio (www.wiltonbio.com), a start-up company based on the Tetricus Science Park, Porton Down.